Skip to main content

Research and development

fath |

FATH Publications

  • Article de journal
    • 2023
      Desvaux, E., Hemon, P., Soret, P., Le Dantec, C., Chatzis, L., Cornec, D., Devauchelle-Pensec, V., Elouej, S., Duguet, F., Laigle, L., Poirier, N., Moingeon, P., Bretin, S., & Pers, J.-O. (2023). High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren’s syndrome. Journal of Autoimmunity, 103147 [1-10]. https://doi.org/10.1016/j.jaut.2023.103147 (Original work published 2023)
    • Michel, L. (2023). Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart. International Journal of Molecular Sciences, 24(9), 7745. https://doi.org/10.3390/ijms24097745 (Original work published 2023)
    • Zaryouh, H., De Pauw, I., Baysal, H., Melis, J., Van den Bossche, V., Hermans, C., Lau, H. W., Lambrechts, H., Merlin, C., Corbet, C., Peeters, M., Vermorken, J. B., De Waele, J., Lardon, F., & Wouters, A. (2023). Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity. Cancer drug resistance, 6(4), 709-728. https://doi.org/10.20517/cdr.2023.62 (Original work published 2023)
    • Balligand, J.-L., Brito, D., Brosteanu, O., Casadei, B., Depoix, C., Edelmann, F., Ferreira, V., Filippatos, G., Gerber, B., Gruson, D., Hasenclever, D., Hellenkamp, K., Ikonomidis, I., Krakowiak, B., Lhommel, R., Mahmod, M., Neubauer, S., Persu, A., Piechnik, S., et al. (2023). Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial. JAMA cardiology, 8(11), 1031-1040. https://doi.org/10.1001/jamacardio.2023.3003 (Original work published 2023)
    • Calvet-Seral, J., Crespo-Yuste, E., Mathys, V., Rodriguez-Villalobos, H., Ceyssens, P.-J., Martin, A., & Gonzalo-Asensio, J. (2023). Targeted Chromosomal Barcoding Establishes Direct Genotype-Phenotype Associations for Antibiotic Resistance in Mycobacterium abscessus. Microbiology Spectrum, 11(3), e0534422 [1-14]. https://doi.org/10.1128/spectrum.05344-22 (Original work published 2023)
    • Bonaccorsi Riani, E., Daudré-Vignier, V., Ciccarelli, O., Coubeau, L., Iesari, S., Castanares Zapatero, D., Collienne, C., Annet, L., Danse, E., Balligand, J.-L., Lefebvre, C., Dieu, A., Benoit, L., & Reding, R. (2023). Improving Safety in Living Liver Donation: Lessons From Intraoperative Adverse Events in 438 Donors Undergoing a Left Liver Resection. Transplantation Direct, 9(9), e1531 [1-11]. https://doi.org/10.1097/TXD.0000000000001531 (Original work published 2023)
    • Tariq, M., De Souza, A., Bensellam, M., Chae, H.-Y., Jaffredo, M., Close, A.-F., Deglasse, J.-P., Santos, L. R. B., Buemi, A., Mourad, N., Wojtusciszyn, A., Raoux, M., Gilon, P., Broca, C., & Jonas, J.-C. (2023). Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped. Diabetologia : clinical and experimental diabetes and metabolism, 66(4), 709-723. https://doi.org/10.1007/s00125-022-05842-y (Original work published 2023)
    • Feron, O., Chang, C.-H., & Végran, F. (2023). Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy. Frontiers in Immunology, 14, 1171274 [1-2]. https://doi.org/10.3389/fimmu.2023.1171274 (Original work published 2023)
    • Dilly, S., Romero Toledo, M., Solier, S., Feron, O., Dessy, C., & Slama Schwok, A. (2023). Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor. Antioxidants (Basel, Switzerland), 12(2), 440 [1-16]. https://doi.org/10.3390/antiox12020440 (Original work published 2023)
    • Spinella, J.-F., Theret, L., Aubert, L., Audemard, E., Boucher, G., Pfammatter, S., Bonneil, E., Bordeleau, M.-È., Thibault, P., Hébert, J., Roux, P. P., & Sauvageau, G. (2023). SPAT: Surface Protein Annotation Tool. bioRxiv. Accepted/in-press. https://doi.org/10.1101/2023.07.07.547075 (Original work published 2023)
    • Vandermeersch, D., Sansen, P.-Y., & Pothen, L. (2023). Bad luck comes in threes. European Journal of Internal Medicine, 115, 130-131. https://doi.org/10.1016/j.ejim.2023.04.030 (Original work published 2023)
    • Balligand, J.-L., & Michel, L. (2023). Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases. Expert Review of Clinical Pharmacology, 16(11), 1073-1084. https://doi.org/10.1080/17512433.2023.2193681 (Original work published 2023)
    • Kerkhove, L., Geirnaert, F., Rifi, A. L., Law, K. L., Gutiérrez, A., Oudaert, I., Corbet, C., Gevaert, T., Dufait, I., & De Ridder, M. (2023). Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer. Cancers, 15(8), 2363 [1-19]. https://doi.org/10.3390/cancers15082363 (Original work published 2023)
    • Neyens, D., Hirsch, T., Abdel Aziz Issa Abdel Hadi, A., Dauguet, N., Vanhaver, C., Bayard, A., Wildmann, C., Luyckx, M., Squifflet, J.-L., D’Hondt, Q., Duhamel, C., Huaux, A., Montiel, V., Dechamps, M., & van der Bruggen, P. (2023). HELIOS-expressing human CD8 T cells exhibit limited effector functions. Frontiers in Immunology, 14, 1308539 [1-15]. https://doi.org/10.3389/fimmu.2023.1308539 (Original work published 2023)
    • Michel, L., Esfahani, H., Verdoy, R., de Mulder, D., Ambroise, J., Roelants, V., Bouchard Bertrand, Savary, J., Dewulf, J. P., Doumont, T., Bouzin, C., Haufroid, V., Luiken, J. J. F. P., Nabben, M., Singleton, M. L., Bertrand, L., Ruiz, M., Des Rosiers, C., Balligand, J.-L., & et al. (2023). A NRF2/beta3-adrenoreceptor axis drives a sustained antioxidant and metabolic rewiring through the pentose-phosphate pathway to alleviate cardiac stress. Biorxiv, 14(Nov (2023) (2023)). https://doi.org/10.1101/2023.11.10.564735 (Original work published 2023)
    • Feron, O., Chang, C.-H., & Végran, F. (2023). Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy. Frontiers in Immunology, 14(()), 1171274. https://doi.org/10.3389/fimmu.2023.1171274 (Original work published 2023)
    • Tan, Y., Lefevre, M., Pierrard, F., Soetens, M., Shoueiry, M., Yildiz, E., Ibanez, S., Özkan, K., Feron, O., Frédérick, R., & Riant, O. (2023). Tandem Heck/Tsuji-Trost Reaction for Uncaging of Alloc-Protected Amines with Palladium Complexes in Living Cells. Journal of Organometallic Chemistry, 996, 122743 [1-9]. https://doi.org/10.1016/j.jorganchem.2023.122743 (Original work published 2023)
    • Colson, A., Depoix, C., Lambert, I., Leducq, C., Bedin, M., De Beukelaer, M., Gatto, L., Loriot, A., Peers de Nieuwburgh, M., Bouhna, K., Baldin, P., Hubinont, C., Sonveaux, P., & Debiève, F. (2023). Specific hypoxia-inducible factor-2 (HIF-2α) inhibitor PT2385 mitigates placental dysfunction in vitro and in a rat model of preeclampsia (RUPP). Hypertension, 80(5), 1011-1023. https://doi.org/10.1161/HYPERTENSIONAHA.122.20739 (Original work published 2023)
    • Yildiz, H., Lepere, C., Zorzi, G., Gheysens, O., Roodhans, F., & Pothen, L. (2023). [18F]FDG-PET/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort. Diagnostics, 13(14), 2316 [1-13]. https://doi.org/10.3390/diagnostics13142316 (Original work published 2023)
    • 2022
      Weber DD, Aminzadeh-Gohari S, Thapa M, Redtenbacher AS, Catalano L, De Miranda Capeloa, T. I., Vazeille, T., Emberger M, Felder TK, Feichtinger RG, Koelblinger P, Dallmann G, Sonveaux, P., Lang R, & Kofler B. (2022). Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity. Cancer & Metabolism, 10(1), 12 [1-20]. https://doi.org/10.1186/s40170-022-00288-7 (Original work published 2022)
    • Kemps, H., Dessy, C., Dumas, L., Sonveaux, P., Alders, L., Van Broekhoven, J., Perez Font, L., Lambrichts, S., Foulquier, S., Hendrix, S., Brone, B., Lemmens, R., & Bronckaers, A. (2022). Extremely low frequency electromagnetic stimulation reduces ischemic stroke volume by improving central collateral blood flow. Journal of cerebral blood flow and metabolism, 42(6), 979-996. https://doi.org/10.1177/0271678X221084410 (Original work published 2022)
    • De Miranda Capeloa, T. I., Van de Velde, J., d’Hose, D., Lipari, S., Derouane, F., Hamelin, L., Bedin, M., Vazeille, T., Duhoux, F., Murphy, M. P., Porporato, P. E., Gallez, B., & Sonveaux, P. (2022). Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice. Cancers, 14(19), 4918 [1-20]. https://doi.org/10.3390/cancers14194918 (Original work published 2022)
    • Richiardone, E., Van den Bossche, V., & Corbet, C. (2022). Metabolic Studies in Organoids: Current Applications, Opportunities and Challenges. Organoids, 1, 85-105. https://doi.org/10.3390/ organoids1010008 (Original work published 2022)
    • Pisapia, P., Li, Z., & Corbet, C. (2022). Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer. Frontiers in Oncology, 12(1), 1. https://doi.org/10.3389/fonc.2022.1035245 (Original work published 2022)
    • Trouvilliez, S., Cicero, J., Lévêque, R., Aubert, L., Corbet, C., Van Outryve, A., Streule, K., Angrand, P.-O., Völkel, P., Magnez, R., Brysbaert, G., Mysiorek, C., Gosselet, F., Bourette, R., Adriaenssens, E., Thuru, X., Lagadec, C., de Ruyck, J., Orian-Rousseau, V., et al. (2022). Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells. Journal of Experimental and Clinical Cancer Research, 41(1), 110 [1-21]. https://doi.org/10.1186/s13046-022-02314-4 (Original work published 2022)
    • Boughaleb, H., Lobysheva, I., Dei Zotti, F., Balligand, J.-L., & Montiel, V. (2022). Biological Assessment of the NO-Dependent Endothelial Function. Molecules, 27(22), 7921 [1-18]. https://doi.org/10.3390/molecules27227921 (Original work published 2022)
    • Buyse, C., Joudiou, N., Warscotte, A., Richiardone, E., Mignion, L., Corbet, C., & Gallez, B. (2022). Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification. Metabolites, 12(6), 12pp. https://doi.org/10.3390/metabo12060557 (Original work published 2022)
    • Blackman, M., De Miranda Capeloa, T. I., Rondeau, J., Zampieri, L., Benyahia, Z., Van de Velde, J., Fransolet, M., Daskalopoulos, E.-P., Michiels, C., Beauloye, C., & Sonveaux, P. (2022). Mitochondrial Protein Cox7b Is a Metabolic Sensor Driving Brain-Specific Metastasis of Human Breast Cancer Cells. Cancers, 14(18), 4371 [1-24]. https://doi.org/10.3390/cancers14184371 (Original work published 2022)
    • Brilot, S., Calvo Lasso De La Vega, E., Michaux, C., Belkhir, L., & Pothen, L. (2022). Hépatite fulminante compliquée d’un syndrome hémophagocytaire réactionnel chez un patient immunocompétent : deux manifestations rares d’une infection à Herpes simplex virus 1. Louvain médical, 141(9-10), 496-501. (Original work published 2022)
    • Montiel, V., Lobysheva, I., Gérard, L., Vermeersch, M., Perez-Morga, D., Castelein, T., Mesland, J.-B., Hantson, P., Collienne, C., Gruson, D., van Dievoet, M.-A., Persu, A., Beauloye, C., Dechamps, M., Belkhir, L., Robert, A., Derive, M., Laterre, P.-F., Danser, A. H. J., et al. (2022). Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine, 77, 103893 [1-18]. https://doi.org/10.1016/j.ebiom.2022.103893 (Original work published 2022)
    • Belo do Nascimento Osorio de Castro, I., Verfaillie, M., Gamze, A., Beckers, P., Joris, V., Desmet, N., Massie, A., & Hermans, E. (2022). AMPK Modulates the Metabolic Adaptation of C6 Glioma Cells in Glucose-Deprived Conditions without Affecting Glutamate Transport. Cells, 11(11), 1800 [1-18]. https://doi.org/10.3390/cells11111800 (Original work published 2022)
    • De Miranda Capeloa, T. I., Krzystyniak, J., d’Hose, D., canas Rodriguez, A., Payen, V. L., Zampieri, L., Van de Velde, J., Benyahia, Z., Pranzini, E., Vazeille, T., Fransolet, M., Bouzin, C., Brusa, D., Michiels, C., Gallez, B., Murphy, M. P., Porporato, P. E., & Sonveaux, P. (2022). MitoQ inhibits human breast cancer cell migration, invasion and clonogenicity. Cancers, 14(6), 1516 [1-20]. https://doi.org/10.3390/cancers14061516 (Original work published 2022)
    • Van de Gucht, M., Dufait, I., Kerkhove, L., Corbet, C., de Mey, S., Jiang, H., Law, K. L., Gevaert, T., Feron, O., & De Ridder, M. (2022). Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions. Cancers, 14(20), 5060 [1-17]. https://doi.org/10.3390/cancers14205060 (Original work published 2022)
    • Catanzaro, E., Feron, O., Skirtach, A. G., & Krysko, D. V. (2022). Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy. Frontiers in Immunology, 13, 925290 [1-18]. https://doi.org/10.3389/fimmu.2022.925290 (Original work published 2022)
    • Ward, B., Yombi, J. C., Balligand, J.-L., Cani, P., Collet, J.-F., De Greef, J., Dewulf, J., Gatto, L., Haufroid, V., Jodogne, S., Kabamba-Mukadi, B., Pyr dit Ruys, S., Vertommen, D., Elens, L., & Belkhir, L. (2022). HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach. Viruses, 14(7), 1373 [1-17]. https://doi.org/10.3390/v14071373 (Original work published 2022)
    • Moghassemi, S., Dadashzadeh, A., Camboni, A., Feron, O., Azevedo, R. B., & Andrade Amorim, C. (2022). Photodynamic therapy using OR141-loaded nanovesicles for eradication of leukemic cells from ovarian tissue. Photodiagnosis and photodynamic therapy, 40, 103139. https://doi.org/10.1016/j.pdpdt.2022.103139 (Original work published 2022)
    • Macchi, C., Moregola, A., Greco, M. F., Svecla, M., Bonacina, F., Dhup, S., Dadhich, R. K., Audano, M., Sonveaux, P., Mauro, C., Mitro, N., Ruscica, M., & Norata, G. D. (2022). Monocarboxylate transporter 1 deficiency impacts CD8 T lymphocytes proliferation and recruitment to adipose tissue during obesity. iScience, 25(6), 104435 [1-26]. https://doi.org/10.1016/j.isci.2022.104435 (Original work published 2022)
    • Descamps, O., Demeure, F., Mertens, A., Verhaegen, A., Balligand, J.-L., Langlois, M., Wallemacq, C., De Sutter, J., Cals, N., & Rietzschel, E. (2022). Acide bempédoïque : nouvelle option thérapeutique pour améliorer le profil lipidique des patients à risque cardiovasculaire élevé. Louvain médical, 141(3), 153-161. (Original work published 2022)
    • Kerick, M., Acosta-Herrera, M., Simeón-Aznar, C. P., Callejas, J. L., Assassi, S., Proudman, S. M., Nikpour, M., Hunzelmann, N., Moroncini, G., de Vries-Bouwstra, J. K., Orozco, G., Barton, A., Herrick, A. L., Terao, C., Allanore, Y., Fonseca, C., Alarcón-Riquelme, M. E., Radstake, T. R. D. J., Beretta, L., et al. (2022). Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. NPJ genomic medicine, 7(1), 57 [1-12]. https://doi.org/10.1038/s41525-022-00327-8 (Original work published 2022)
    • Ippolito, L., Sonveaux, P., & Chiarugi, P. (2022). Unconventional roles of lactate along the tumor and immune landscape. Trends in Endocrinology and Metabolism, 33(4), 231-235. https://doi.org/10.1016/j.tem.2022.01.005 (Original work published 2022)
    • Van den Bossche, V., Zaryouh, H., Vara-Messler, M., Vignau, J., Machiels, J.-P., Wouters, A., Schmitz, S., & Corbet, C. (2022). Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resistance Updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 60(1), 100806 [1-20]. https://doi.org/10.1016/j.drup.2022.100806 (Original work published 2022)
    • Ippolito, L., Sonveaux, P., & Chiarugi, P. (2022). Lactate: unconventional roles of a nutrient along the tumor landscape. Trends in Endocrinology and Metabolism, 33(4), 231-235. (Original work published 2022)
    • Bernard, A. (2022). Dermal Exposure to Hazardous Chemicals in Baby Diapers: A Re-Evaluation of the Quantitative Health Risk Assessment Conducted by The French Agency for Food, Environmental and Occupational Health and Safety (ANSES). International journal of environmental research and public health, 19(7), 4159 [1-18]. https://doi.org/10.3390/ijerph19074159 (Original work published 2022)
    • Tallarico, R. T., Deniau, B., Fong, N., Ghosn, J., & Legrand, M. (2022). Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients. Intensive care medicine, 48(9), 1245-1247. https://doi.org/10.1007/s00134-022-06797-9 (Original work published 2022)
    • Thabault, L., Brustenga, C., Savoyen, P., Van Gysel, M., Wouters, J., Sonveaux, P., Frédérick, R., & Liberelle, M. (2022). Discovery of small molecules interacting at lactate dehydrogenases tetrameric interface using a biophysical screening cascade. European Journal of Medicinal Chemistry, 230, 114102 [1-10]. https://doi.org/10.1016/j.ejmech.2022.114102 (Original work published 2022)
    • Cappellesso, F., Orban, M.-P., Shirgaonkar, N., Berardi, E., Serneels, J., Neveu, M.-A., di Molfetta, D., Piccapane, F., Caroppo, R., Debellis, L., Ostyn, T., Joudiou, N., Mignion, L., Richiardone, E., Jordan, B., Gallez, B., Corbet, C., Roskams, T., Dasgupta, R., et al. (2022). Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Nature cancer, 3(12), 1464-1483. https://doi.org/10.1038/s43018-022-00470-2 (Original work published 2022)
    • d’Hose, D., Mignion, L., Hamelin, L., Sonveaux, P., Jordan, B., & Gallez, B. (2022). Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization? Biomolecules, 12(10), 1418 [1-14]. https://doi.org/10.3390/biom12101418 (Original work published 2022)
    • d’Hose, D., Mathieu, B., Mignion, L., Hardy, M., Ouari, O., Jordan, B., Sonveaux, P., & Gallez, B. (2022). EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells. Molecules (Basel, Switzerland), 27(18), 5872. https://doi.org/10.3390/molecules27185872 (Original work published 2022)
    • Delcorte, O., Craps, J., Mahibullah, S., Spourquet, C., D’Auria, L., Van Der Smissen, P., Dessy, C., Marbaix, E., Mourad, M., & Pierreux, C. (2022). Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer. Endocrine - Related Cancer, 29(7), 389-401. https://doi.org/10.1530/ERC-21-0343 (Original work published 2022)
    • Yildiz, H., Pothen, L., Lefebvre, C., De Greef, J., Belkhir, L., Vincent, A., Roodhans, F., Balligand, J.-L., Yombi, J. C., & Hainaut, P. (2022). Innovations 2021 en médecine interne et maladies infectieuses. Louvain médical, 141(2), 103-107. (Original work published 2022)
    • Pothen, L., Verdoy, R., De Mulder, D., Esfahani, H., Farah, C., Michel, L., Dei Zotti, F., Bearzatto, B., Ambroise, J., Bouzin, C., Dessy, C., & Balligand, J.-L. (2022). Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of “Vascular Memory”. Frontiers in Cardiovascular Medicine, 9, 854361 [1-13]. https://doi.org/10.3389/fcvm.2022.854361 (Original work published 2022)
    • De Miranda Capeloa, T. I., Krzystyniak, J., Canas Rodriguez, A., Payen, V. L., Zampieri, L., Pranzini, E., Derouane, F., Vazeille, T., Bouzin, C., Duhoux, F., Murphy, M. P., Porporato, P. E., & Sonveaux, P. (2022). MitoQ prevents human breast cancer recurrence and lung metastasis in mice. Cancers, 14(6), 1488 [1-13]. https://doi.org/10.3390/cancers14061488 (Original work published 2022)
    • Yelek, C., Mignion, L., Paquot, A., Bouzin, C., Corbet, C., Muccioli, G., Cani, P., & Jordan, B. (2022). Tumor Metabolism Is Affected by Obesity in Preclinical Models of Triple-Negative Breast Cancer. Cancers, 14(3), 562 [1-16]. https://doi.org/10.3390/cancers14030562 (Original work published 2022)
    • Ferté, L., Cumps, J., Battault, S., Esfahani, H., Balligand, J.-L., Horman, S., Bertrand, L., Beauloye, C., & Marino, A. (2022). Letter by Ferté, et al. Regarding Article, “Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice”. International Heart Journal, 63(1), 184-186. https://doi.org/10.1536/ihj.21-442 (Original work published 2022)
    • Dechamps, M., De Poortere, J., Martin, M., Gatto, L., Daumerie, A., Bouzin, C., Octave, M., Ginion, A., Robaux, V., Pirotton, L., Bodart, J., Gérard, L., Montiel, V., Campion, A., Gruson, D., van Dievoet, M.-A., Douxfils, J., Haguet, H., Morimont, L., et al. (2022). Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study. Frontiers in Medicine, 8, 780750 [1-14]. https://doi.org/10.3389/fmed.2021.780750 (Original work published 2022)
    • Sancho, P., & Feron, O. (2022). Editorial: Insights in pharmacology of anti-cancer drugs: 2021. Frontiers in Pharmacology, 13, 1062640 [1-2]. https://doi.org/10.3389/fphar.2022.1062640 (Original work published 2022)
    • Delprat, V., Huart, C., Feron, O., Soncin, F., & Michiels, C. (2022). The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: Enhanced tumor inflammation and metastasis. Frontiers in Oncology, 12, 961753 [1-14]. https://doi.org/10.3389/fonc.2022.961753 (Original work published 2022)
    • Deskeuvre, M., Lan, J., Dierge, E., Messens, J., Riant, O., Corbet, C., Feron, O., & Frédérick, R. (2022). Targeting cancer cells in acidosis with conjugates between the carnitine palmitoyltransferase 1 inhibitor etomoxir and pH (low) insertion peptides. International Journal of Pharmaceutics, 624(1), 122041. https://doi.org/10.1016/j.ijpharm.2022.122041 (Original work published 2022)
    • Johanns, M., Corbet, C., Jacobs, R., Drappier, M., Bommer, G., Herinckx, G., Vertommen, D., Tajeddine, N., Young, D., Messens, J., Feron, O., Steinberg, G. R., Hue, L., & Rider, M. H. (2022). Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators. The Biochemical journal, 479(12), 1317-1336. https://doi.org/10.1042/BCJ20220170 (Original work published 2022)
    • Lan, J., Cadassou, O., Corbet, C., Riant, O., & Feron, O. (2022). Discovery of Mitochondrial Complex I Inhibitors as Anticancer and Radiosensitizer Drugs Based on Compensatory Stimulation of Lactate Release. Cancers, 14(21), 5454 [1-15]. https://doi.org/10.3390/cancers14215454 (Original work published 2022)
    • Choteau, M., Scohy, A., Messe, S., Luyckx, M., Dechamps, M., Montiel, V., Yombi, J. C., Gruson, D., Limaye, N., Michiels, T., & Dumoutier, L. (2022). Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection. Scientific Reports, 12(1), 2077 [1-12]. https://doi.org/10.1038/s41598-022-06038-5 (Original work published 2022)
    • Craps, J., Joris, V., Baldeschi, L., Daumerie, C., Camboni, A., Buemi, A., Lengelé, B., Behets Wydemans, C., Boschi, A., Mourad, M., Many, M.-C., & Dessy, C. (2022). miR-199a Downregulation as a Driver of the NOX4/HIF-1α/VEGF-A Pathway in Thyroid and Orbital Adipose Tissues from Graves’ Patients. International journal of molecular sciences, 23(1), 153 [1-18]. https://doi.org/10.3390/ijms23010153 (Original work published 2022)
    • Derouane, F., van Marcke de Lummen, C. J., Berlière, M., Gerday, A., Fellah, L., Leconte, I., Van Bockstal, M., Galant, C., Corbet, C., & Duhoux, F. (2022). Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. Cancers, 14(16), 3876 [1-31]. https://doi.org/10.3390/cancers14163876 (Original work published 2022)
    • Spourquet, C., Delcorte, O., Lemoine, P., Dauguet, N., Loriot, A., Achouri, Y., Hollmén, M., Jalkanen, S., Huaux, F., Lucas, S., Van Meerbeeck, P., Knauf, J., Fagin, J. A., Dessy, C., Mourad, M., Henriet, P., Tyteca, D., Marbaix, E., & Pierreux, C. (2022). BRAFV600E expression in thyrocytes causes recruitment of immunosuppressive STABILIN-1 macrophages. Cancers, 14(19), 4687 [1-21]. https://doi.org/10.3390/cancers14194687 (Original work published 2022)
    • Sambon, P., Sellimi, A., Kozyreff, A., Gheysens, O., Pothen, L., Yildiz, H., & Van Pesch, V. (2022). Epidemiology, clinical presentation, treatment, and outcome of neurosarcoidosis: A mono-centric retrospective study and literature review. Frontiers in Neurology, 13, 970168. https://doi.org/10.3389/fneur.2022.970168 (Original work published 2022)
    • 2021
      Pothen, L., Yildiz, H., Samnick, M. M., & Yombi, J. C. (2021). Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? Clinical Rheumatology, 40(4), 1649-1657. https://doi.org/10.1007/s10067-020-05572-9 (Original work published 2021)
    • Maury, E., Navez, B., & Brichard, S. (2021). Circadian clock dysfunction in human omental fat links obesity to metabolic inflammation. Nature Communications, 12(1), 2388 [1-17]. https://doi.org/10.1038/s41467-021-22571-9 (Original work published 2021)
    • Michel, L., & Balligand, J.-L. (2021). Bèta-3-adrenerge receptoragonisten : therapeutisch potentieel bij de behandeling van prediabetes en hartfalen. Bloedvaten Hart Longen, 26(4), 27-32. (Original work published 2021)
    • Van Regemorter, E., Joris, V., Van Regemorter, V., Marique, L., Behets Wydemans, C., Lengelé, B., Boschi, A., Baldeschi, L., Daumerie, C., Many, M.-C., & Craps, J. (2021). Downregulation of Caveolin-1 and Upregulation of Deiodinase 3, Associated with Hypoxia-Inducible Factor-1α Increase, Are Involved in the Oxidative Stress of Graves’ Orbital Adipocytes. Thyroid, 31(4), 627-637. https://doi.org/10.1089/thy.2020.0238 (Original work published 2021)
    • Michel, L., & Balligand, J.-L. (2021). Les agonistes des récepteurs adrénergiques Beta-3 : potentiel thérapeutique dans le traitement du prédiabète et de l’insuffisance cardiaque. Vaisseaux cœur poumons, 26(4), 27-32. (Original work published 2021)
    • Yildiz, H., Castanares Zapatero, D., Hannesse, C., Vandermeersch, D., Pothen, L., & Yombi, J. C. (2021). Prospective validation and comparison of COVID-GRAM, NEWS2, 4C mortality score, CURB-65 for the prediction of critical illness in COVID-19 patients. Infectious Diseases, 53(8), 640-642. https://doi.org/10.1080/23744235.2021.1896777 (Original work published 2021)
    • Ughetto, S., Migliore, C., Pietrantonio, F., Apicella, M., Petrelli, A., D’Errico, L., Durando, S., Moya-Rull, D., Bellomo, S. E., Rizzolio, S., De Miranda Capeloa, T. I., Ribisi, S., Degiuli, M., Reddavid, R., Rapa, I., Fumagalli, U., De Pascale, S., Ribero, D., Baronchelli, C., et al. (2021). Personalized therapeutic strategies in HER2-driven gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 24(4), 897-912. https://doi.org/10.1007/s10120-021-01165-w (Original work published 2021)
    • Benyahia, Z., Blackman, M., Hamelin, L., Zampieri, L., De Miranda Capeloa, T. I., Bedin, M., Vazeille, T., Schakman, O., & Sonveaux, P. (2021). In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment. Cancers, 13(3), 569. https://doi.org/10.3390/cancers13030569 (Original work published 2021)
    • Balligand, J.-L., & Michel, L. (2021). Assembling fats and sugar for cardiac protection. European Heart Journal (English Edition), 42(13), 4493-4495. https://doi.org/10.1093/eurheartj/ehab606 (Original work published 2021)
    • Lysy, P., Absil, H., Gasser, E., Boughaleb, H., Barrea, T., & Moniotte, S. (2021). Combined Algorithm-Based Adaptations of Insulin Dose and Carbohydrate Intake During Exercise in Children With Type 1 Diabetes: Results From the CAR2DIAB Study. Frontiers in Endocrinology, 12, 658311 [1-8]. https://doi.org/10.3389/fendo.2021.658311 (Original work published 2021)
    • Zampieri, L., Da Silva Almeida, A. C., Rondeau, J., & Sonveaux, P. (2021). Mitochondrial Transfer in Cancer: A Comprehensive Review. International Journal of Molecular Sciences, 22(6), 3245. https://doi.org/10.3390/ijms22063245 (Original work published 2021)
    • Zampieri, L., Sboarina, M., Cacace, A., Grasso, D., Thabault, L., Hamelin, L., Vazeille, T., Dumon, E., Rossignol, R., Frédérick, R., Sonveaux, E., Lefranc, F., & Sonveaux, P. (2021). Olaparib is a mitochondrial Complex I inhibitor that kills temozolomide-resistant human glioblastoma cells. International Journal of Molecular Sciences, 22(11938), 17. https://doi.org/10.3390/ijms222111938 (Original work published 2021)
    • Hepp, M., Wérion, A., De Greef, A., de Ville de Goyet, C., de Bournonville, M., Behets Wydemans, C., Lengelé, B., Daumerie, C., Mourad, M., Ludgate, M., Many, M.-C., Joris, V., & Craps, J. (2021). Oxidative Stress-Induced Sirtuin1 Downregulation Correlates to HIF-1α, GLUT-1, and VEGF-A Upregulation in Th1 Autoimmune Hashimoto’s Thyroiditis. International Journal of Molecular Sciences (Print), 22(8), 3806 [1-17]. https://doi.org/10.3390/ijms22083806 (Original work published 2021)
    • Poncin, W., Baudet, L., Reychler, G., Duprez, F., Liistro, G., Belkhir, L., Pothen, L., Yildiz, H., Yombi, J. C., & De Greef, J. (2021). Impact of an improvised system on preserving oxygen supplies in patients with COVID- 19. Archivos de Bronconeumologia, 57, 77-79. https://doi.org/10.1016/j.arbres.2020.07.019 (Original work published 2021)
    • Martin Corrons, I., Braem, F., Baudet, L., Poncin, W., Fizaine, S., Aboubakar Nana, F., Froidure, A., Pilette, C., Liistro, G., De Greef, J., Yildiz, H., Pothen, L., Yombi, J. C., Belkhir, L., & Reychler, G. (2021). Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation. Respiratory Medicine, 183, 106438 [1-5]. https://doi.org/10.1016/j.rmed.2021.106438 (Original work published 2021)
    • Dufeys, C., Daskalopoulos, E.-P., Castanares Zapatero, D., Conway, S. J., Ginion, A., Bouzin, C., Ambroise, J., Bearzatto, B., Gala, J.-L., Heymans, S., Papageorgiou, A.-P., Vinckier, S., Cumps, J., Balligand, J.-L., Vanhaverbeke, M., Sinnaeve, P., Janssens, S., Bertrand, L., Beauloye, C., & Horman, S. (2021). AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism. Basic Research in Cardiology, 116, 10 [1-20]. https://doi.org/10.1007/s00395-021-00846-y (Original work published 2021)
    • Collin, A., Lecocq, M., Detry, B., Carlier, F., Bouzin, C., De Sany, P., Hoton, D., Verleden, S., Froidure, A., Pilette, C., & Gohy, S. (2021). Loss of ciliated cells and altered airway epithelial integrity in cystic fibrosis. Journal of Cystic Fibrosis, 20(6), e129-e139. https://doi.org/10.1016/j.jcf.2021.09.019 (Original work published 2021)
    • Moghassemi, S., Dadashzadeh, A., Azevedo, R. B., Feron, O., & Amorim, C. A. (2021). Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system. Journal of controlled release : official journal of the Controlled Release Society, 339, 75-90. https://doi.org/10.1016/j.jconrel.2021.09.024 (Original work published 2021)
    • Dierge, E., Debock, E., Guilbaud, C., Corbet, C., Mignolet, E., Mignard, L., Bastien, E., Dessy, C., Larondelle, Y., & Feron, O. (2021). Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metabolism, S1550-4131(21), 00233-00233. https://doi.org/10.1016/j.cmet.2021.05.016 (Original work published 2021)
    • Vermonden, P., Vancoppenolle, M., Dierge, E., Mignolet, E., Cuvelier, G., Knoops, B., Page, M., Debier, C., Feron, O., & Larondelle, Y. (2021). Punicic Acid Triggers Ferroptotic Cell Death in Carcinoma Cells. Nutrients, 13(8), 2751 [1-16]. https://doi.org/10.3390/nu13082751 (Original work published 2021)
    • Boulanger, C., Chatzis, O., Nolf, D., Brichard, B., Lauwerys, B., Nassogne, M.-C., Limaye, N., & et al. (2021). Atypical phenotype? The answer’s in the genotype: AGS caused by a novel RNASEH2C variant combined with XLA caused by a BTK deficiency. Rheumatology (Print), 60(7), e240-e242. https://doi.org/10.1093/rheumatology/keab051 (Original work published 2021)
    • Colson, A., Depoix, C., Dessilly, G., Baldin, P., Danhaive, O., Hubinont, C., Sonveaux, P., & Debiève, F. (2021). Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2. The American Journal of Pathology : cellular and molecular biology of disease, 191(9), 1610-1623. https://doi.org/10.1016/j.ajpath.2021.05.009 (Original work published 2021)
    • Colson, A., Sonveaux, P., Debiève, F., & Sferruzzi-Perri, A. N. (2021). Adaptations of the human placenta to hypoxia: opportunities for interventions in fetal growth restriction. Human Reproduction Update, 27(3), 531-569. https://doi.org/10.1093/humupd/dmaa053 (Original work published 2021)
    • van Marcke de Lummen, C. J., Honoré, N., van der Elst, A., Beyaert, S., Derouane, F., Dumont, C., Aboubakar Nana, F., Baurain, J.-F., Borbath, I., Collard, P., Cornelis, F., De Cuyper, A., Duhoux, F., Filleul, B., Galot, R., Gizzi, M., Mazzeo, F., Pieters, T., Seront, E., et al. (2021). Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study. BMC Cancer, 21(1), 578 [1-12]. https://doi.org/10.1186/s12885-021-08349-8 (Original work published 2021)
    • Guilmot, A., Maldonado Slootjes, S. I., Sellimi, A., Bronchain, M., Hanseeuw, B., Belkhir, L., Yombi, J. C., De Greef, J., Pothen, L., Yildiz, H., Duprez, T., Fillee, C., Anantharajah, A., Capes, A., Hantson, P., Jacquerye, P., Raymackers, J.-M., London, F., El Sankari, S., et al. (2021). Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. Journal of neurology, 268(3), 751-757. https://doi.org/10.1007/s00415-020-10108-x (Original work published 2021)
    • Vander Linden, C., Corbet, C., Bastien, E., Martherus, R., Guilbaud, C., Petit, L., Wauthier, L., Loriot, A., De Smet, C., & Feron, O. (2021). Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition. Cell Reports, 35(9), 109202. https://doi.org/10.1016/j.celrep.2021.109202 (Original work published 2021)
    • Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento-Ribeiro, A. B. (2021). Impact of cancer metabolism on therapy resistance – Clinical implications. Drug Resistance Updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 100797. https://doi.org/10.1016/j.drup.2021.100797 (Original work published 2021)
    • Vincenti, M., Farah, C., Amedro, P., Scheuermann, V., Lacampagne, A., & Cazorla, O. (2021). Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice. Cardiovascular Drugs and Therapy, 1-11. https://doi.org/10.1007/s10557-021-07218-7 (Original work published 2021)
    • Balligand, J.-L., & Bertrand, L. (2021). You “heart” what you eat! Cardiovascular Research, 117(11), 2294-2296. https://doi.org/10.1093/cvr/cvab118 (Original work published 2021)
    • Morelle, J., Marechal, C., Yu, Z., Debaix, H., Corre, T., Lambie, M., Verduijn, M., Dekker, F., Bovy, P., Evenepoel, P., Bammens, B., Selgas, R., Bajo, M. A., Coester, A. M., Sow-Diallo, A., Hautem, N., Struijk, D. G., Krediet, R. T., Balligand, J.-L., et al. (2021). AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis. New England Journal of Medicine, 385(17), 1570-1580. https://doi.org/10.1056/nejmoa2034279 (Original work published 2021)
    • Humby, F., Durez, P., Buch, M. H., Lewis, M. J., Rizvi, H., Rivellese, F., Nerviani, A., Giorli, G., Mahto, A., Montecucco, C., Lauwerys, B., Ng, N., Ho, P., Bombardieri, M., Romão, V. C., Verschueren, P., Kelly, S., Sainaghi, P. P., Gendi, N., et al. (2021). Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. The Lancet, 397(10271), 305-317. https://doi.org/10.1016/S0140-6736(20)32341-2 (Original work published 2021)
    • Ngo Njembe, M. T., Pachikian, B., Lobysheva, I., Van Overstraeten, N., Dejonghe, L., Verstraelen, E., Buchet, M., Rasse, C., Gardin, C., Mignolet, E., Balligand, J.-L., & Larondelle, Y. (2021). A Three-Month Consumption of Eggs Enriched With ω-3, ω-5 and ω-7 Polyunsaturated Fatty Acids Significantly Decreases the Waist Circumference of Subjects at Risk of Developing Metabolic Syndrome: A Double-Blind Randomized Controlled Trial. Nutrients, 13(2), 663 [1-17]. https://doi.org/10.3390/nu13020663 (Original work published 2021)
    • Soret, P., Le Dantec, C., Desvaux, E., Foulquier, N., Chassagnol, B., Hubert, S., Jamin, C., Barturen, G., Desachy, G., Devauchelle-Pensec, V., Boudjeniba, C., Cornec, D., Saraux, A., Jousse-Joulin, S., Barbarroja, N., Rodríguez-Pintó, I., De Langhe, E., Beretta, L., Chizzolini, C., et al. (2021). A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome. Nature Communications, 12(1), 3523 [1-18]. https://doi.org/10.1038/s41467-021-23472-7 (Original work published 2021)
    • Lasswitz, L., Gunesch, A. P., Kasten, M., Zapatero-Belinchon, F. J., Brogden, G., Gerold, G., Pietschmann, T., Montiel, V., Balligand, J.-L., Facciotti, F., Hirsch, E., Gausepohl, T., Elbahesh, H., Rimmelzwaan, G. F., Höfer, A., Kühnel, M. P., Jonigk, D., Eigendorf, J., Tegtbur, U., et al. (2021). Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One, 16(8), e0255335 [1-24]. https://doi.org/10.1371/journal.pone.0255335 (Original work published 2021)
    • Thabault, L., Liberelle, M., Koruza, K., Yildiz, E., Joudiou, N., Messens, J., Brisson, L., Wouters, J., Sonveaux, P., & Frédérick, R. (2021). Discovery of a novel lactate dehydrogenase tetramerization domain using epitope mapping and peptides. Journal of Biological Chemistry, 296, 100422. https://doi.org/10.1016/j.jbc.2021.100422 (Original work published 2021)
    • Yildiz, H., Castanares Zapatero, D., Pierman, G., Pothen, L., De Greef, J., Aboubakar Nana, F., Rodriguez-Villalobos, H., Belkhir, L., & Yombi, J. C. (2021). Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients. International journal of general medicine, 14, 5111-5117. https://doi.org/10.2147/IJGM.S326666 (Original work published 2021)
    • Froidure, A., Mahsouli, A., Liistro, G., De Greef, J., Belkhir, L., Gérard, L., Bertrand, A., Koenig, S., Pothen, L., Yildiz, H., Mwenge, G. B., Aboubakar Nana, F., Gohy, S., Pilette, C., Reychler, G., Coche, E., Yombi, J. C., & Ghaye, B. (2021). Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respiratory Medicine, 181, 106383 [1-6]. https://doi.org/10.1016/j.rmed.2021.106383 (Original work published 2021)
    • De Greef, J., Scohy, A., Zech, F., Aboubakar Nana, F., Pilette, C., Gérard, L., Pothen, L., Yildiz, H., Belkhir, L., & Yombi, J. C. (2021). Determinants of IgG antibodies kinetics after severe and critical COVID-19. Journal of Medical Virology, 93(9), 5416-5424. https://doi.org/10.1002/jmv.27059 (Original work published 2021)
    • Gérard, L., Lecocq, M., Bouzin, C., Hoton, D., Schmit, G., Pinto Pereira, J., Montiel, V., Plante-Bordeneuve, T., Laterre, P.-F., & Pilette, C. (2021). Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine, 204(9), 1024-1034. https://doi.org/10.1164/rccm.202012-4461OC (Original work published 2021)
    • Van Den Brûle, S., Rappe, M., Ambroise, J., Bouzin, C., Dessy, C., Paquot, A., Muccioli, G., & Lison, D. (2021). Diesel exhaust particles alter the profile and function of the gut microbiota upon subchronic oral administration in mice. Particle and Fibre Toxicology, 18(1), 7 [1-15]. https://doi.org/10.1186/s12989-021-00400-7 (Original work published 2021)
    • Virga, F., Cappellesso, F., Stijlemans, B., Henze, A.-T., Trotta, R., Van Audenaerde, J., Mirchandani, A. S., Sanchez-Garcia, M. A., Vandewalle, J., Orso, F., Riera-Domingo, C., Griffa, A., Ivan, C., Smits, E., Laoui, D., Martelli, F., Langouche, L., Van den Berghe, G., Feron, O., et al. (2021). Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation. Science advances, 7(19), eabf0466. https://doi.org/10.1126/sciadv.abf0466 (Original work published 2021)
    • Valenti, M. T., Mottes, M., Dalle Carbonare, L., & Feron, O. (2021). Editorial: Bone Metastases. Frontiers in Oncology, 11, 741515. https://doi.org/10.3389/fonc.2021.741515 (Original work published 2021)
    • Buyse, C., Joudiou, N., Corbet, C., Feron, O., Mignion, L., Flament, J., & Gallez, B. (2021). Impact of Inhibition of the Mitochondrial Pyruvate Carrier on the Tumor Extracellular pH as Measured by CEST-MRI. Cancers, 13(17), 4278. https://doi.org/10.3390/cancers13174278 (Original work published 2021)
    • Triaille, C., Durez, P., Sokolova, T., Tilman, G., Méric de Bellefon, L., Galant, C., Coulie, P., Lauwerys, B., & Limaye, N. (2021). Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue. Frontiers in Immunology, 12, 724895 [1-9]. https://doi.org/10.3389/fimmu.2021.724895 (Original work published 2021)
  • Brevet
  • Papier de conférence
    • 2023
      Aubert, L., Özkan, K., Guilbaud, C., Bruno, P., Srhir, S., & Feron, O. (2023). Deciphering the interplay between circadian clock and tumor metabolism to optimize anticancer chronotherapies. BACR (Belgian Association for Cancer Research) Annual Meeting, Bruxelles (Belgium).
    • Aubert, L., Özkan, K., Srhir, S., Bruno, P., Guilbaud, C., & Feron, O. (2023). Deciphering the interplay between circadian rhythms and metabolic preferences in colorectal cancer cells and 3D spheroids. Gordon Research Seminar: “Biological Timekeepers: Models, Mechanisms and Physiology”, Bates College.
    • 2022
      Sonveaux, P. (2022). Towards the prevention of local recurrence and distant metastases in breast cancer. Meeting Series of the Royal Society of Chemistry (RSC) - Belgian Section, Louvain-la-Neuve (online).
    • Triaille, C., Sokolova, T., De Montjoye, S., Nzeusseu Toukap, A., Meric de Bellefon, L., Loriot, A., Lauwerys, B., Durez, P., & Limaye, N. (2022). POS0448 Synovial transcriptomic profiles correlate with disease activity in early untreated rheumatoid arthritis. Annals of the rheumatic diseases, 81(Suppl 1), 478. https://doi.org/10.1136/annrheumdis-2022-eular.4957 (Original work published 2022)
    • Grasso, D., & Sonveaux, P. (2022). Preservation of mitochondrial integrity participates in radioresistance in head and neck mouse cancer models. ESTRO 2022, Copenhaguen, Denmark.
    • Sonveaux, P. (2022). Metastasis prevention (in breast cancer) with superoxide scavengers. Radiotherapy Online-Seminar Series of the University of Maastricht/MUMC/Maastro, Maastricht, The Netherlands.
    • 2021
      Sonveaux, P. (2021). Lactate signals pseudohypoxia in cancer. EMBO workshop: lactate: unconventional roles of a nutrient along tumor landscape, Florence, Italy.
    • Sonveaux, P. (2021). Opening lecture: preventing cancer metastasis with superoxide scavengers. 9th International Symposium of Gunma University for Advanced Research: Breakthroughs in Cancer Metabolism and Technological Pers, Gunma, Japan.
    • Sonveaux, P. (2021). Mitochondrial superoxide at the core of the metastatic process of cancers. Journée Mitochondrie Métabolisme et Cancer, Angers University, France.
    • Sonveaux, P., & Frédérick, R. (2021). Identification and development of LDH inhibitors to treat cancer. Seminar Series of the European Institute of Chemistry and Biology (IECB).
    • De Miranda Capeloa, T. I., Paolo E Porporato, & Sonveaux, P. (2021). Preventing cancer metastasis with specific inhibitors of mitochondrial superoxide. 33rd AICC Annual conference: International Meeting on Cancer Metabolism, Turin, Italy.
    • Sonveaux, P. (2021). Preventing cancer metastasis with superoxide scavengers. 4th Metabolism & Cancer conference, Bordeaux, France.
    • Vanderputten, M., Aboubakar Nana, F., Bouzin, C., Hoton, D., Stanciu Pop, C. M., Lecocq, M., Ambroise, J., Pilette, C., & Ocak, S. (2021). Prognostic Significance of IgA+ B Cells in Non-Small Cell Lung Cancer [P72.10]. Journal of Thoracic Oncology, 16(3), S569. https://doi.org/10.1016/j.jtho.2021.01.1028 (Original work published 2021)
    • Dumas, L., Metzinger, T., Marchand, D., Esfahani, H., Kurbanova, S., Maistriaux, L., Bastien, E., Daskalopoulos, E.-P., Horman, S., & Dessy, C. (2021). MiR-199a is differentially regulated during physiological and pathological cardiac hypertrophy. European Journal of Heart Failure, 23(Suppl 1), 9. https://doi.org/10.1002/ejhf.2100 (Original work published 2021)
  • Thèse

Within the FATH Unit, the research groups led by Profs O. Feron and P. Sonveaux carry out research in oncology, the specific focus of which is the integration of the cancer cell in its relationship with the host. The expertise of these two groups in understanding the tumour microenvironment (hypoxia, acidosis and host cells) and the metabolic determinants of many cancers provides researchers with an original prism for dissecting the biological mechanisms leading to disease progression.

Within the host tissue, cancer cells must continually struggle to meet the bioenergetic and biosynthetic requirements necessary for their survival and proliferation. This metabolic adaptation plays an active role in metastatic dissemination and resistance to treatment. The mechanisms involved, in particular via modulation of the stroma (intercellular cooperation, angiogenesis, immune anergy, etc.), are examined using cell and animal models adapted to the types of cancer studied.

Several translational projects arising from this research are aimed at the preclinical and clinical development of new anti-cancer drugs targeting different aspects of tumour cell biology, including mitochondrial oxidative stress, reticulum stress and autophagy.

The FATH unit has recognised expertise in the analysis of signalling and pharmacology, in particular that of nitric oxide synthases (NOS) in the heart and blood vessels. In particular, FATH has developed techniques for analysing the molecular regulation of membrane receptors and intracellular effectors (including NOS) in animal and human myocardium and vessels (e.g. via PI3K- and Akt-dependent phosphorylation, interaction with chaperones such as hsp90, and other regulators such as caveolins). FATH uses different strains of transgenic mice and cardiovascular tissues of human origin obtained in collaboration with Clinical Services at the IREC. Within the Pole, the laboratory is equipped with state-of-the-art instruments for biochemical, molecular and cellular analyses (including IONOPTIX platforms equipped to measure sarcomeric shortening and calcium fluorescence in myocytes) and animal phenotyping (e.g. by miniaturised implantable telemetry for mice).

Biology of NO synthases. Following on from the work of Prof. J-L. Balligand and Prof. C. Dessy on the role of NO in cardiac contractility and vascular relaxation respectively, these projects are studying the transcriptional and post-translational regulation of NO synthetase isoforms, eNOS, nNOS and iNOS in in vitro cell cultures and animal models (in vivo) of cardiovascular pathologies.

Study of the endothelial phenotype characteristic of ischaemia/reperfusion conditions. This work aims to identify the molecular determinants of post-ischaemic angiogenesis (Prof. O. Feron) and to better characterise the phenomenon of ischaemic preconditioning at the origin of the survival advantages for cells of the cardiovascular system exposed to haemodynamic stress (Prof. C. Dessy).

Mechanistic study of the determinants of adaptive or maladaptive remodelling of the stressed myocardium. Initially carried out in collaboration with a European network ("EUGeneHeart" Consortium, subsidised by the European Commission) and a transatlantic network of excellence (subsidised by the Fondation Leducq), this project includes the study of paracrine factors influencing the tissue regeneration potential of cardiac progenitor cells and signalling between cardiac myocytes and fibroblasts and endothelial cells. The reciprocal influence of metabolism on remodelling (including stem cell biology) is studied in the context of different myocardial stresses (haemodynamic overload, neuro-humoral stimulation).

For all these projects, the new mechanistic targets are validated in humans using human tissues and bioinformatics analysis of polymorphisms in databases from GWAS studies.

A good example is the characterisation of the role of the Beta3 adrenergic receptor in the human myocardium, which justified the launch of a randomised, controlled and prospective clinical trial testing the protective effect of a Beta3 adrenergic agonist in patients at risk of developing heart failure with preserved ejection fraction.